Extended-Release Melatonin in Patients With Rapid Eye Movement Sleep Behavior Disorder

NATerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 1, 2022

Primary Completion Date

February 1, 2024

Study Completion Date

February 1, 2024

Conditions

Rapid Eye Movement Sleep Behavior DisorderParkinson Disease

Interventions

DIETARY_SUPPLEMENT

Immediate Release Melatonin

5 mg orally every night at 9 pm for 4 weeks

DIETARY_SUPPLEMENT

Extended Release Melatonin

5 mg orally every night at 9 pm for 4 weeks

Trial Locations (1)

Mayo Clinic Florida, Jacksonville